Transduction and apoptosis induction in the rat prostate, using adenovirus vectors

Human Gene Therapy

Volumn 12, Issue 12, 2001, Pages 1499-1512

  Kirkman, Wayne ^a   Chen, Ping ^a   Schroeder, Rosanna ^a   Feneley, Mark R ^b   Rodriguez, Ronald ^b   Wickham, Thomas J ^a   King, C Richter ^a   Bruder, Joseph T ^a  

^a GenVec   (United States)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; BETA GALACTOSIDASE; FAS LIGAND; LUCIFERASE; POLYLYSINE; VIRUS RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL TYPE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; ENZYME ACTIVITY; EPITHELIUM CELL; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; HUMAN; MALE; NICK END LABELING; NONHUMAN; PROSTATE; PROSTATE CARCINOMA; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; RAT; SMOOTH MUSCLE FIBER; STROMA CELL; VIROGENESIS;

ADENOVIRIDAE; ANIMALS; APOPTOSIS; BETA-GALACTOSIDASE; CALCIUM PHOSPHATES; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EPITHELIAL CELLS; FAS LIGAND PROTEIN; FLOW CYTOMETRY; GENETIC VECTORS; HUMANS; HYPERPLASIA; IN SITU NICK-END LABELING; LUCIFERASES; MALE; MEMBRANE GLYCOPROTEINS; MUSCLE, SMOOTH; POLY(ADP-RIBOSE) POLYMERASES; PROSTATE; RATS; TRANSDUCTION, GENETIC; TUMOR CELLS, CULTURED;

ADENOVIRIDAE; ANIMALIA; DNA VIRUSES;

EID: 0035573668     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/10430340152480230     Document Type: Article

References (52)

1. Treatment of experimental glioma by administration of adenoviral vectors expressing Fas ligand
2. Gene transfer of Fas ligand induces tumor regression in vivo
3. Polycations increase the efficiency of adenovirus-mediated gene transfer to epithelial and endothelial cells in vitro
4. Mutations that alter an Arg-Gly-Asp (RGD) sequence in the adenovirus type 2 penton base protein abolish its cell-rounding activity and delay virus reproduction in flat cells
5. Isolation of a common receptor for coxsackie B viruses and adenoviruses 2 and 5
6. The murine CAR homolog is a receptor for coxsackie B viruses and adenoviruses
7. Self-association of the death domains of the p55 tumor necrosis
8. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death
9. Improved production of adenovirus vectors expressing apoptotic transgenes
10. Interaction of the adenovirus 14.7-kDa protein with FLICE inhibits Fas ligand-induced apoptosis
11. Physical mapping of a large-plaque mutation of adenovirus type 2
12. Hormone-regulated apoptosis results from reentry of differentiated prostate cells onto a defective cell cycle
13. Zonal variation of apoptosis and proliferation in the normal prostate and in benign prostatic hyperplasia
14. Fas antigen/CD-95 upregulation and activation during castration-induced regression of the rat ventral prostate gland
15. An adenovirus vector with genetically modified fibers demonstrates expanded tropism via utilization of a coxsackievirus and adenovirus receptor-independent cell entry mechanism
16. Complexes of adenovirus with polycationic polymers and cationic lipids increase the efficiency of gene transfer in vitro and in vivo
17. Incorporation of adenovirus in calcium phosphate precipitates enhances gene transfer to airway epithelia in vitro and in vivo
18. Fas and Fas ligand in embryos and adult mice: Ligand expression in several immune-privileged tissues and coexpression in adult tissues characterized by apoptotic cell turnover
19. Expression of alpha v beta 5 integrin is necessary for efficient adenovirus-mediated gene transfer in the human airway
20. Gradient of RGD-dependent entry of adenoviral vector in nasal and intrapulmonary epithelia: Implications for gene therapy of cystic fibrosis
21. Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells
22. Relationship between atypical adenomatous hyperplasia (AAH), prostatic intraepithelial neoplasia (PIN) and prostatic adenocarcinoma
23. Inhibition of death receptor signals by cellular FLIP
24. Programmed cell death in animal development
25. Modification of the genetic program of human alveolar macrophages by adenovirus vectors in vitro is feasible but inefficient, limited in part by the low level of expression of the coxsackie/adenovirus receptor
26. Selective gene delivery to head and neck cancer cells via an integrin targeted adenoviral vector
27. Advanced generation adenoviral vectors possess augmented gene transfer efficiency based upon coxsackie adenovirus receptor-independent cellular entry capacity
28. Activation of programmed cell death in the rat ventral prostate after castration
29. FasL induces Fas/Apo1-mediated apoptosis in human embryonic kidney 293 cells routinely used to generate E1-deleted adenoviral vectors
30. Delivery of adenoviral vectors to the prostate for gene therapy
31. Normal histology of the prostate
32. Differential susceptibility of primary and established human glioma cells to adenovirus infection: Targeting via the epidermal growth factor receptor achieves fiber receptor-independent gene transfer
33. FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex
34. Expression of the primary coxsackie and adenovirus receptor is downregulated during skeletal muscle maturation and limits the efficacy of adenovirus-mediated gene delivery to muscle cells
35. Efficient Fas-ligand gene expression in rodent liver after intravenous injection of a recombinant adenovirus by the use of a Cre-mediated switching system
36. Limited entry of adenovirus vectors into well-differentiated airway epithelium is responsible for inefficient gene transfer
37. Insertion of an RGD motif into the HI loop of adenovirus fiber protein alters the distribution of transgene expression of the systemically administered vector
38. Caspases: Intracellular signaling by proteolysis
39. Antitumor effect of locally produced CD95 ligand
40. Apoptosis by retrovirus- and adenovirus-mediated gene transfer of Fas ligand to glioma cells: Implications for gene therapy
41. Highly augmented cytopathic effect of a fiber-mutant E1B-defective adenovirus for gene therapy of gliomas
42. HCAR and MCAR: The human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses
43. Implications of maturation for viral gene delivery to skeletal muscle
44. Basolateral localization of fiber receptors limits adenovirus infection from the apical surface of airway epithelia
45. Adenovirus technology for gene manipulation and functional studies
46. Targeting adenovirus
47. Integrins alpha v beta 3 and alpha v beta 5 promote adenovirus internalization but not virus attachment
48. Adenovirus targeted to heparan-containing receptors increases its gene delivery efficiency to multiple cell types
49. Increased in vitro and in vivo gene transfer by adenovirus vectors containing chimeric fiber proteins
50. Fas ligand is not only expressed in immune privileged human organs but is also coexpressed with Fas in various epithelial tissues
51. Lack of high affinity fiber receptor activity explains the resistance of ciliated airway epithelia to adenovirus infection
52. Application of a Fas ligand encoding a recombinant adenovirus vector for prolongation of transgene expression